China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.91% | 2.56% | 20.32% | 23.61% | 27.75% |
| Total Depreciation and Amortization | 7.52% | -49.99% | -70.30% | -69.22% | -68.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.68% | 65.84% | 98.01% | 71.42% | -45.94% |
| Change in Net Operating Assets | 861.92% | -22.24% | -92.27% | -92.27% | -92.27% |
| Cash from Operations | 2.21% | 9.87% | 15.29% | -3.60% | -20.21% |
| Capital Expenditure | 3.87% | -17.77% | -42.74% | -22.71% | -5.11% |
| Sale of Property, Plant, and Equipment | -64.51% | -60.04% | -55.40% | 23.44% | 387.60% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 152.09% | -- | -- | -- |
| Other Investing Activities | -273.31% | -8.40% | 586.97% | 172.12% | -5.57% |
| Cash from Investing | -429.02% | -58.24% | 219.83% | 127.32% | -4.55% |
| Total Debt Issued | 10.00% | 10.00% | 10.00% | 110.00% | -- |
| Total Debt Repaid | -4,384.19% | -4,382.36% | -4,380.52% | -2,062.64% | 10.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -24.97% | -24.67% | -23.61% | -23.84% | -24.42% |
| Other Financing Activities | -141.66% | -278.47% | -1,057.02% | -624.77% | -311.90% |
| Cash from Financing | -1,544.81% | -1,566.84% | -1,464.62% | -42.64% | 91.20% |
| Foreign Exchange rate Adjustments | -832.34% | -329.06% | -79.15% | -54.01% | -2.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.32% | -37.75% | -7.24% | -3.49% | 0.71% |